Dr. Almut Winterstein elected to the Academy of Science, Engineering and Medicine of Florida
Fourteen members of the class of 2022 were officially inducted at the ASEMFL Annual Meeting in Orlando on Nov. 5.
Posts tagged as
Almutwinterstein
UF Health researchers find quinolone ear drops associated with tendon ruptures
Research by Patrick Antonelli, M.D., and Almut Winterstein, Ph.D., shows quinolone ear drops used to treat infection increase the risk of tendon ruptures.
Dr. Winterstein honored with special ISPE award for COVID-19 pandemic contributions
Dr. Winterstein was one of nine ISPE members honored with the award at the 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Copenhagen, Denmark.
From Florida Podcast: What is Florida’s medical marijuana research consortium studying – and what has it found so far?
Almut Winterstein, Ph.D., joined the From Florida podcast with Nicci Brown to discuss medical marijuana research.
UF study finds 1 in 16 women take harmful drugs during pregnancy
The study published in the American Journal of Obstetrics and Gynecology highlights the need for women and their providers to carefully examine medications taken during pregnancy.
UF researchers determine the risk of pregnancy loss associated with a commonly used immunosuppressant drug, effective risk management strategies are warranted
The research provides important information to support the FDA’s REMS program which aims to prevent fetal exposure to mycophenolate.
UF Health researchers develop CMS quality measure to evaluate inpatient psychiatric hospitals
The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.
UF study finds excess use of loop diuretics following initiation of dihydropyridine calcium channel blockers
The study published in JAMA Network Open found a substantial number of patients are being prescribed a loop diuretic for leg swelling induced by calcium channel blocker.
Dr. Almut Winterstein presents at FDA-wide seminar
At the meeting, she was presented an "Outstanding Service Award," for her exceptional leadership in the field of drug safety.
UF study finds FDA strategy cuts fetal exposure to harmful immunosuppressive drug, but risks remain
University of Florida researchers determined an FDA-approved program deters pregnant women from starting a potentially harmful immunosuppressive drug. But for women taking the drug, the program was not effective at reducing conception.
